Viewing Study NCT04710628


Ignite Creation Date: 2025-12-26 @ 10:34 AM
Ignite Modification Date: 2025-12-31 @ 8:18 PM
Study NCT ID: NCT04710628
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-02
First Post: 2020-12-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents
Sponsor: MedSIR
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module